Mercado de medicamentos de inmunoterapia: mapeo competitivo y perspectivas estratégicas para 2031

  • Report Code : TIPRE00003416
  • Category : Life Sciences
  • No. of Pages : 150
Buy Now

Se espera que el mercado de medicamentos para inmunoterapia crezca desde 186,32 mil millones de dólares en 2021 a 476.040 millones de dólares en 2031; se espera que crezca a una tasa compuesta anual del 14,4 % entre 2022 y 2031.

La creciente demanda de anticuerpos monoclonales se ha atribuido al crecimiento del mercado de medicamentos para inmunoterapia. Los anticuerpos monoclonales utilizados en inmunoterapia se producen artificialmente a partir de un clon celular y, por lo tanto, constan de un solo tipo de inmunoglobulina. Están dirigidos a antígenos específicos y se unen a los antígenos para formar un complejo. Los anticuerpos monoclonales se pueden utilizar para tratar enfermedades como el cáncer, la artritis reumatoide, la esclerosis múltiple, el lupus eritematoso sistémico y las enfermedades cardiovasculares. Según la Administración de Alimentos y Medicamentos (FDA), se aprobaron más de 450 anticuerpos monoclonales hasta 2021. En febrero de 2022, la FDA emitió una autorización de uso de emergencia (EUA) para bebtelovimab, un nuevo anticuerpo monoclonal que es eficaz contra la variante omicrón del SARS-CoV-2 . El fármaco fue eficaz en pacientes adultos y pediátricos con síntomas leves a moderados o en aquellos que tienen un alto riesgo de progresión a COVID-19 grave.

DINÁMICA DEL MERCADO
El crecimiento del mercado de medicamentos de inmunoterapia se atribuye principalmente a la creciente demanda de enfermedades objetivo, la creciente demanda de biosimilares y anticuerpos monoclonales y la creciente adopción de categorías de medicamentos de inmunoterapia en comparación con los métodos de tratamiento tradicionales. Sin embargo, los desafíos relacionados con la fabricación de medicamentos de inmunoterapia están obstaculizando el crecimiento del mercado. Además, la creciente demanda de tratamientos medicinales personalizados está impulsando el crecimiento del mercado de medicamentos de inmunoterapia durante el período previsto.

Perspectivas estratégicas

ÁMBITO DEL MERCADO
El &ldquo ;Análisis del mercado global de medicamentos de inmunoterapia hasta 2031” El informe tiene como objetivo proporcionar una descripción general del mercado de medicamentos de inmunoterapia con una segmentación detallada del mercado según el tipo, la indicación clínica y el usuario final. El informe proporciona estadísticas clave del mercado basadas en el desempeño de los principales actores. También ofrece tendencias y oportunidades clave en el mercado.

SEGMENTACIÓN DEL MERCADO
El mercado mundial de medicamentos de inmunoterapia está segmentado por tipo , indicación clínica y usuario final. Según el tipo, el mercado se segmenta en adyuvantes de vacunas, activadores de células dendríticas y adyuvantes de vacunas. factores de crecimiento, estimuladores de células T y factores de crecimiento, inhibidores de puntos de control inmunitario, anticuerpos monoclonales, interleucinas y interferones y otros. Según las indicaciones, el mercado se segmenta en cáncer, enfermedades inflamatorias, enfermedades autoinmunes, enfermedades infecciosas y otras. El segmento de usuarios finales se divide aún más en hospitales y hospitales. clínicas, centros quirúrgicos ambulatorios y otros.


El mercado mundial de medicamentos de inmunoterapia está segmentado en cinco regiones principales: América del Norte, Europa, Asia Pacífico y Medio Oriente. &erio; África y el Sur y el Sur. Centroamérica. El informe cubre análisis y pronósticos de 18 países de todo el mundo junto con las tendencias y oportunidades que prevalecen en la región.

Desde la perspectiva regional, América del Norte domina el mercado de medicamentos de inmunoterapia con ~40% de participación de mercado en 2021. El crecimiento del mercado en la región se atribuye principalmente a la presencia de un gran número de fabricantes de medicamentos de inmunoterapia como F. Hoffmann-La Roche Ltd., Pfizer Inc., Merck & Co, Novartis International AG, Johnson & Johnson, Sanofi y GlaxoSmithKline Plc. La siguiente figura muestra la tendencia de crecimiento de los ingresos en el mercado de medicamentos de inmunoterapia de América del Norte:

Immunotherapy Drugs Market

< span style="font-family: verdana, geneva, sans-serif; font-size: 10pt;">Fuente: The Insight Partners Analysis

El informe analiza factores que afectan, como impulsores, restricciones, oportunidades y tendencias futuras, que impactan el mercado de medicamentos de inmunoterapia. . También proporciona un análisis exhaustivo de las cinco fuerzas de Porter de los factores que afectan el mercado de medicamentos de inmunoterapia.

IMPACTO DE LA PANDEMIA COVID-19

El brote de COVID-19 provocó un aumento de la demanda de medicamentos de inmunoterapia, lo que generó un gran volumen de pedidos entre los fabricantes de medicamentos, lo que resultó en un mayor volumen de producción. El aumento de los volúmenes de producción aumentó los beneficios de los productos de varios fabricantes de componentes farmacéuticos. Así, la adquisición de componentes farmacológicos creció durante la fase inicial de propagación del SARS-CoV-2, impulsando así el crecimiento del mercado mundial de medicamentos de inmunoterapia.

La mayor parte de la demanda se observó desde el objetivo adyuvantes de vacunas. La Administración de Alimentos y Medicamentos de EE. UU. (FDA) ha concedido autorización de uso de emergencia para las vacunas contra la COVID-19 de Pfizer/BioNTech y Moderna. Estos medicamentos han sido recomendados por profesionales de la salud a personas mayores de 16 años, con una dosis de 30 µg (0,3 m) a un costo de 19,50 dólares estadounidenses. Como resultado, ha aumentado la adquisición de medicamentos, lo que reforzará el mercado de medicamentos de inmunoterapia durante el período de pronóstico.

JUGADORES DEL MERCADO
El informe cubre novedades clave en el mercado de medicamentos de inmunoterapia. Varias empresas se están centrando en estrategias de crecimiento orgánico, como lanzamientos de productos, aprobaciones de productos, patentes y eventos. Las estrategias de crecimiento inorgánico, como adquisiciones, asociaciones y colaboraciones, han fomentado la expansión de los negocios y la base de clientes de los actores del mercado. Se prevé que los actores del mercado que operan en el mercado de medicamentos de inmunoterapia experimentarán oportunidades de crecimiento lucrativas en los próximos años con la creciente demanda de medicamentos de inmunoterapia.

El informe también incluye los perfiles de los principales fármacos de inmunoterapia empresas del mercado, junto con su análisis FODA y estrategias de mercado. Además, el informe se centra en los principales actores de la industria con información como perfiles de empresas, componentes y servicios ofrecidos, información financiera de los últimos tres años y desarrollos clave en los últimos cinco años. La lista de algunas empresas dedicadas al mercado de medicamentos de inmunoterapia se menciona a continuación:

    Incyte CorporationJuno Therapeutics•< span style="font-family: verdana, geneva, sans-serif; font-size: 10pt;">Celldex Therapeutics•Tesaro, Inc.F. Hoffmann-La Roche LtdAmgen Inc.Novartis AGBioNTech SESanofiGlaxoSmithKline PlcPfizer Inc.< /span>•Merck & CoJohnson & Johnson

El dedicado equipo de investigación y análisis de Insight Partner está formado por profesionales experimentados con experiencia estadística avanzada y ofrece varias opciones de personalización en el estudio existente.

< img style="display: bloque; margen izquierdo: automático; margen derecho: automático;" src="https://www.theinsightpartners.com/assets/rdimages/immunotherapy-drugs-market-img2.png" alt="Investigación de mercado" width="350" height="350">

  • Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
  • PEST and SWOT Analysis
  • Market Size Value / Volume - Global, Regional, Country
  • Industry and Competitive Landscape
  • Excel Dataset
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What is the expected CAGR of the Immunotherapy Drugs Market?

Immunotherapy Drugs Market is expected to grow at a CAGR of 15.5% between 2023-2031

What are the driving factors impacting the Immunotherapy Drugs Market?

The driving factors impacting the Immunotherapy Drugs Market are: Rising Cancer Prevalence, Advancements in Immunotherapy Research

What are the future trends of the Immunotherapy Drugs Market?

The future trends of the Immunotherapy Drugs Market are: Personalized Immunotherapy, Combination Therapies

Which are the leading players operating in the Immunotherapy Drugs Market?

The leading players in the Immunotherapy Drugs Market are: Incyte Corporation, Juno Therapeutics, Celldex Therapeutics Tesaro, Inc., F. Hoffmann-La Roche Ltd , Amgen Inc., Novartis AG, BioNTech SE, Sanofi, GlaxoSmithKline Plc, Pfizer Inc., Merck & Co, Johnson & Johnson

What are the deliverable formats of the Immunotherapy Drugs Market report?

The report can be delivered in PDF/PPT format; we can also share excel dataset based on the request.

What are the options available for the customization of this report?

Some of the customization options available based on request are additional 3–5 company profiles and country-specific analysis of 3–5 countries of your choice. Customizations are to be requested/discussed before making final order confirmation, as our team would review the same and check the feasibility.

Trends and growth analysis reports related to Life Sciences : READ MORE..   
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

The List of Companies

1. Eli Lilly and Company
2. Astrazeneca
3. Abbvie
4. Amgen inc
5. GlaxoSmithKline Plc
6. Novartis International AG
7. Merck and Co., Inc
8. F. Hoffmann-La Roche AG
9. Bristol-Myers Squibb
10. UbiVac


Buy Now  

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.